Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate CancerKim N., Celio Kussumoto, Ji Youl Lee et al.|Journal of Clinical Oncology|2023Cited by 317
Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651Robert I. Haddad, Athanassios Argiris, Kevin J. Harrington et al.|Journal of Clinical Oncology|2022Cited by 159
Pembrolizumab with or Without Lenvatinib As First-line Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC): Phase 3 LEAP-010 StudyLisa Licitra, Robert I. Haddad, Makoto Tahara et al.|International Journal of Radiation Oncology*Biology*Physics|2024Cited by 32